The amplification or over-expression of the Cyclin E1 (CCNE1) and the Vestigial Like Growth Factor 3 (VGLL3), in addition to the functional loss of TRP53, are among the most common genetic alterations found in STS patients29. This evidence concerns the gene VGLL3 and telomere syndrome.